Seth Reno serves as Executive at Gemphire Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Seth Reno has executed 3 insider transactions totaling $140.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 24, 2019 involved receiving (via award) 100,000 shares valued at $0.
Seth Reno currently holds 118,286 shares of Gemphire Therapeutics Inc. (GEMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Seth Reno has been a net buyer of GEMP stock. They have purchased $140.0K and sold $0 worth of shares.
Seth Reno's most recent insider trade was on Jul 24, 2019, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.00 |
| Discretionary |
| Aug 10, 2016 | GEMP | $40.0K | Purchase | 4,000 | $10.00 | Discretionary |